The single most common pathogen behind healthcare-associated infections (HAIs) in the United States is Clostridioides difficile, accounting for 15% of all HAIs with a known pathogen. But the broader answer depends on whether you’re asking about a specific germ or a type of infection. Device-related infections from catheters and ventilators, surgical site infections, and gut infections caused by antibiotic use all rank among the leading categories. Together, HAIs affect roughly 1.7 million hospitalized patients in the U.S. each year, and about 1 in 17 of those patients dies as a result.
C. Difficile: The Leading Single Pathogen
C. difficile is a bacterium that causes severe, sometimes life-threatening diarrhea and inflammation of the colon. It thrives in hospital environments for a straightforward reason: antibiotics. When patients receive antibiotics to treat one infection, those drugs also wipe out the protective bacteria in the gut. That creates an opening for C. difficile spores, which are remarkably hardy and can survive on surfaces for months, to take hold and multiply.
What makes C. difficile especially problematic is how easily it spreads between patients. The spores resist standard alcohol-based hand sanitizers and many common disinfectants, meaning they persist on bed rails, call buttons, and bathroom fixtures. Once a patient develops a C. difficile infection, the cycle of antibiotic treatment can become self-reinforcing, since the very drugs used to fight it can set up conditions for recurrence.
Other Major Bacterial Culprits
Bacteria cause the vast majority of HAIs, followed by fungi and then viruses. Beyond C. difficile, the most frequently involved bacteria fall into two broad groups. Gram-positive organisms include Staphylococcus aureus (the bacterium behind staph infections and MRSA), Streptococcus species, and Enterococcus species. Gram-negative organisms include E. coli, Klebsiella, Pseudomonas, and Acinetobacter, which are especially concerning in intensive care settings.
Many of these bacteria have developed resistance to multiple antibiotics. A CDC analysis found that hospital-onset infections caused by multidrug-resistant organisms increased by at least 15% between 2019 and 2020 alone. In one large study at a German university medical center, multidrug-resistant organisms accounted for nearly 60% of all HAIs. That means more than half of hospital-acquired infections involve bacteria that don’t respond to first-line treatments, making them harder to manage and more dangerous.
Fungal infections, primarily from Candida species, collectively rank as the fourth most common HAI pathogen. Candida auris, an emerging multidrug-resistant fungal species, has drawn particular global concern because it’s difficult to identify with standard lab tests and frequently resists treatment. Viral infections, by contrast, account for only 1% to 5% of all HAIs and are most commonly linked to unsafe needle practices in resource-limited settings.
How Medical Devices Drive Infections
Urinary catheters, central venous lines, and ventilator tubes are among the most common entry points for infection. The mechanism is straightforward but difficult to prevent entirely. Within 24 hours of a device being placed in the body, bacteria can attach to its surface and begin forming a biofilm: a thin, sticky layer of microorganisms encased in a protective coating of sugary molecules they produce themselves.
Once a biofilm forms, it becomes extremely difficult to treat. The protective coating shields bacteria from both the immune system and antibiotics, which is why infections tied to indwelling devices often can’t be resolved until the device is removed. The body’s own proteins, including platelets and plasma components, actually help the process along by creating a conditioning film on the device surface that makes it easier for bacteria to latch on.
This is why one of the CDC’s core prevention practices focuses specifically on reassessing whether a patient still needs an invasive device during every clinical encounter. The goal is to identify the earliest safe opportunity for removal, because every additional day a catheter or tube stays in place increases infection risk.
Why HAIs Are So Costly
The financial toll of HAIs is substantial. Patients who develop a hospital-acquired infection face hospitalization costs roughly 2.1 times higher than patients without one. In one controlled study, the median cost per hospitalization was $3,851 for infected patients compared to $1,813 for uninfected patients, a difference driven by longer stays, additional treatments, and complications.
The human cost is steeper. In that same study, 7.8% of patients with HAIs died, and 54% of all recorded deaths occurred among patients who had developed hospital-acquired infections. These aren’t patients who were necessarily sicker to begin with. They acquired a new infection during treatment for something else entirely.
What Actually Reduces Infection Rates
Hand hygiene remains the single most important preventive measure, though compliance among healthcare workers is far from universal. Research published in Emerging Infectious Diseases found that every 10% improvement in hand hygiene compliance was associated with a 6% drop in overall HAIs and a 14% reduction in C. difficile infections specifically. Those numbers may sound modest, but scaled across an entire hospital system, they translate to thousands of prevented infections per year.
The CDC’s core prevention framework goes well beyond hand washing, though. It includes requiring job-specific infection prevention training for all healthcare staff before they begin duties and at least annually after that. It calls for active monitoring of whether staff actually follow protocols, with prompt feedback when they don’t. Environmental cleaning and disinfection, proper use of personal protective equipment, safe injection practices, and reprocessing of reusable medical equipment all form part of the baseline standard for every patient encounter.
For patients known or suspected to carry highly transmissible organisms, hospitals implement additional precautions on top of these standard measures: dedicated equipment, gowns and gloves for anyone entering the room, and sometimes private rooms with controlled airflow. The framework also addresses something less obvious but equally important: leadership accountability. The CDC recommends that hospital governing bodies be directly responsible for infection prevention programs and allocate sufficient resources to run them, rather than treating infection control as a secondary concern.
Surveillance systems for tracking HAIs exist across most high-income countries, but the World Health Organization notes they are virtually nonexistent in most low- and middle-income countries. That gap makes it difficult to estimate the true global burden, though it almost certainly exceeds the numbers reported in well-resourced settings where infections are more likely to be caught and counted.